4-(6-AMinopyridin-3-yl)-N,N-diMethylbenzaMide
|
- $120 - $452
- Product name: 4-(6-AMinopyridin-3-yl)-N,N-diMethylbenzaMide
- CAS: 1314987-53-5
- MF: C14H15N3O
- MW: 241.29
- EINECS:
- MDL Number:MFCD19684164
- Synonyms:4-(6-AMinopyridin-3-yl)-N,N-diMethylbenzaMide;Benzamide, 4-(6-amino-3-pyridinyl)-N,N-dimethyl-
5 prices
Selected condition：
Brand
- AK Scientific
- Chemenu
- Crysdot
- SynChem
- TRC
Package
- 500mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product numberZ9605
- Product description4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide
- Packaging1g
- Price$211
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM319580
- Product description4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide 95%
- Packaging5g
- Price$426
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11295725
- Product description4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide 95+%
- Packaging5g
- Price$452
- Updated2021-12-16
- Buy
- ManufacturerSynChem
- Product numberSC-40896
- Product description4-(6-AMINOPYRIDIN-3-YL)-N,N-DIMETHYLBENZAMIDE 95%
- Packaging1g
- Price$120
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA616680
- Product description4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide
- Packaging500mg
- Price$185
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | Z9605 | 4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide | 1g | $211 | 2021-12-16 | Buy |
| Chemenu | CM319580 | 4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide 95% | 5g | $426 | 2021-12-16 | Buy |
| Crysdot | CD11295725 | 4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide 95+% | 5g | $452 | 2021-12-16 | Buy |
| SynChem | SC-40896 | 4-(6-AMINOPYRIDIN-3-YL)-N,N-DIMETHYLBENZAMIDE 95% | 1g | $120 | 2021-12-16 | Buy |
| TRC | A616680 | 4-(6-Aminopyridin-3-yl)-N,N-dimethylbenzamide | 500mg | $185 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|